These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17306085)

  • 1. [Intravenous milrinone in the treatment of pediatric heart failure].
    Han XZ; Sun Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):73-4. PubMed ID: 17306085
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure.
    Gold J; Cullinane S; Chen J; Seo S; Oz MC; Oliver JA; Landry DW
    Am J Cardiol; 2000 Feb; 85(4):506-8, A11. PubMed ID: 10728962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous milrinone in treatment of advanced congestive heart failure.
    Zewail AM; Nawar M; Vrtovec B; Eastwood C; Kar MN; Delgado RM
    Tex Heart Inst J; 2003; 30(2):109-13. PubMed ID: 12809251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy Support of a Pediatric Patient Receiving Milrinone at Home.
    Xue A; Dersch-Mills D; Tsang C; Greenway SC
    Can J Hosp Pharm; 2016; 69(5):415-419. PubMed ID: 27826160
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
    Curley M; Liebers J; Maynard R
    J Infus Nurs; 2017; 40(2):92-96. PubMed ID: 28248808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase inhibitors. Its role in heart failure therapy.
    Kohn IJ; Ribeiro LG
    Arq Bras Cardiol; 1990 Jun; 54(6):361-5. PubMed ID: 1963059
    [No Abstract]   [Full Text] [Related]  

  • 8. Milrinone in meningococcal sepsis.
    Rich N; West N; McMaster P; Alexander J
    Pediatr Crit Care Med; 2003 Jul; 4(3):394-5. PubMed ID: 12840611
    [No Abstract]   [Full Text] [Related]  

  • 9. Community-acquired bacterial meningitis.
    Johnston AM; Carr B
    N Engl J Med; 2006 Mar; 354(13):1429-32; author reply 1429-32. PubMed ID: 16575957
    [No Abstract]   [Full Text] [Related]  

  • 10. Milrinone.
    Bell SG
    Neonatal Netw; 2003; 22(4):61-3. PubMed ID: 12934750
    [No Abstract]   [Full Text] [Related]  

  • 11. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe heart failure: balancing length and quality of life.
    Harv Heart Lett; 1999 Jun; 9(10):1-2. PubMed ID: 10233785
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous milrinone in patients with severe congestive cardiac failure awaiting heart transplantation.
    Skoyles JR; Sherry KM; Price C
    J Cardiothorac Vasc Anesth; 1992 Apr; 6(2):222-5. PubMed ID: 1568013
    [No Abstract]   [Full Text] [Related]  

  • 14. Milrinone in pediatric heart failure and pulmonary hypertension: Is meta-analyses the answer?
    Lone AM; Kanthimathinathan HK
    Eur J Pediatr; 2024 Mar; 183(3):1473-1474. PubMed ID: 38147129
    [No Abstract]   [Full Text] [Related]  

  • 15. Diuretic effect of phosphodiesterase inhibitors depends on baseline renal function in patients with congestive heart failure.
    Kanda M; Yasuda S; Goto Y; Sumida H; Baba T; Noguchi T; Nonogi H
    Am J Cardiol; 1999 Apr; 83(8):1274-7, A9. PubMed ID: 10215299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Milrinone on Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    Kaye DM; Nanayakkara S; Vizi D; Byrne M; Mariani JA
    J Am Coll Cardiol; 2016 May; 67(21):2554-6. PubMed ID: 27230053
    [No Abstract]   [Full Text] [Related]  

  • 17. Proper use of phosphodiesterase inhibitors according to the situations.
    Tanwiphongtrakun T; Inoue S; Furuya H
    Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):183-5. PubMed ID: 17037008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of milrinone as a pharmacological bridge to heart transplantation.
    Koyanagi T; Kyo S; Ouchi H; Asano H; Yokote Y; Omoto R
    Jpn J Thorac Cardiovasc Surg; 2000 Jul; 48(7):460-3. PubMed ID: 10965621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of protein kinase A for a hepato-protective mechanism of milrinone pretreatment.
    Satoh K; Kume M; Abe Y; Uchinami H; Yakubouski SV; Takahashi T; Sato T; Yamamoto Y
    J Surg Res; 2009 Jul; 155(1):32-9. PubMed ID: 19111324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN) is in its infancy.
    Kissoon N
    J Crit Care; 2006 Jun; 21(2):223. PubMed ID: 16769472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.